Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis

Figure 1

Flow diagram for selection of studies treating patients with conventional treatment or together with alprostadil treatment (figure created by Review Manager software version 5.3, The Nordic Cochrane Centre, and The Cochrane Collaboration, 2014).